Robert A. Burger

ORCID: 0009-0005-2993-6616 · 3 papers in corpus
other 2017
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
Gynecologic Oncology ·doi:10.1016/j.ygyno.2017.08.004

PURPOSE: We examined disparities in prognosis between patients with ovarian clear cell carcinoma (OCCC) and serous epithelial ovarian cancer (SOC). METHODS: We reviewed data from FIGO stage I-IV epithelial ovarian cancer patients who parti…

lab-animal 2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-10-0169

This study examines the role of vascular endothelial growth factor (VEGF) as a therapeutic target in clear cell carcinoma (CCC) of the ovary, which has been regarded as a chemoresistant histologic subtype. Immunohistochemical analysis using…

observational 1995
Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis
Gynecologic Oncology ·doi:10.1006/gyno.1995.1271

In order to better understand the clinical presentation and biologic behavior of ovarian carcinomas arising in endometriosis, we performed a historical cohort study of all women with endometrioid adenocarcinoma of the ovary (ECO) diagnosed …